NO943115D0 - Hematologikontrollsammensetning for leukocyttanaloger; og fremgangsmåte for fremstilling og anvendelse - Google Patents

Hematologikontrollsammensetning for leukocyttanaloger; og fremgangsmåte for fremstilling og anvendelse

Info

Publication number
NO943115D0
NO943115D0 NO943115A NO943115A NO943115D0 NO 943115 D0 NO943115 D0 NO 943115D0 NO 943115 A NO943115 A NO 943115A NO 943115 A NO943115 A NO 943115A NO 943115 D0 NO943115 D0 NO 943115D0
Authority
NO
Norway
Prior art keywords
cell
leukocyte
analogs
hemoglobin
analogues
Prior art date
Application number
NO943115A
Other languages
English (en)
Other versions
NO943115L (no
Inventor
Carole Young
Michael N Elliott
Nancy R Naylor
Timothy J Fischer
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Corp filed Critical Coulter Corp
Publication of NO943115D0 publication Critical patent/NO943115D0/no
Publication of NO943115L publication Critical patent/NO943115L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/102499—Blood gas standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO943115A 1992-02-24 1994-08-23 Hematologikontrollsammensetning for leukocyttanaloger; og fremgangsmåte for fremstilling og anvendelse NO943115L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84043592A 1992-02-24 1992-02-24
PCT/US1993/001855 WO1993017330A1 (en) 1992-02-24 1993-02-17 Hematology control composition for leukocyte analogs; and methods for their preparation and use

Publications (2)

Publication Number Publication Date
NO943115D0 true NO943115D0 (no) 1994-08-23
NO943115L NO943115L (no) 1994-09-01

Family

ID=25282374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943115A NO943115L (no) 1992-02-24 1994-08-23 Hematologikontrollsammensetning for leukocyttanaloger; og fremgangsmåte for fremstilling og anvendelse

Country Status (11)

Country Link
US (2) US5320964A (no)
EP (1) EP0628167B1 (no)
JP (1) JP3391451B2 (no)
KR (1) KR950700539A (no)
AT (1) ATE195810T1 (no)
AU (1) AU665413B2 (no)
BR (1) BR9305952A (no)
CA (1) CA2129832A1 (no)
DE (1) DE69329274T2 (no)
NO (1) NO943115L (no)
WO (1) WO1993017330A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
EP0628167B1 (en) * 1992-02-24 2000-08-23 Coulter Corporation Hematology control composition for leukocyte analogs; and methods for their preparation and use
US6509192B1 (en) 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US6362003B1 (en) * 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
US5631165A (en) * 1994-08-01 1997-05-20 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5656499A (en) * 1994-08-01 1997-08-12 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5891734A (en) * 1994-08-01 1999-04-06 Abbott Laboratories Method for performing automated analysis
AU3972195A (en) * 1994-10-12 1996-05-06 Research & Diagnostics Systems, Inc. Reticulocyte assay control
EP0771420A1 (en) * 1995-04-28 1997-05-07 Coulter International Corp. Quality control method of hematology instruments
US5858790A (en) * 1996-06-26 1999-01-12 Abbott Laboratories Hematology reference control and method of preparation
US6146901A (en) * 1997-06-16 2000-11-14 Hematronix, Inc. Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition
US5994139A (en) * 1998-04-07 1999-11-30 Coulter International Corp. Stable hematology control composition and method of use
US6221668B1 (en) * 1999-08-20 2001-04-24 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6200500B1 (en) 1999-08-20 2001-03-13 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6444471B1 (en) 1999-10-18 2002-09-03 Research & Diagnostic Systems, Inc. Reticulocyte containing complete blood control
US6653063B2 (en) 2000-06-12 2003-11-25 Hematronix, Inc. Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same
CA2411088C (en) * 2000-06-12 2009-12-22 Hematronix, Inc. Hematology composition using preserved white blood cells
US6569682B2 (en) * 2001-07-27 2003-05-27 Coulter International Corp. Hematology control product with increased closed vial stability
CA2463693C (en) 2001-10-16 2012-08-28 Kiwi Ingenuity Limited Sensitivity controls for blood serology prepared from modified cells
US6759246B1 (en) * 2001-11-30 2004-07-06 Research & Diagnostic Systems, Inc. Hematology control composition including lymphocyte analogs and method for preparation and use
US6723563B2 (en) 2001-12-03 2004-04-20 Streck Laboratories Inc. Hematology reference control
US6653137B2 (en) 2001-12-03 2003-11-25 Streck Laboratories Inc. Hematology reference control
US7247484B2 (en) * 2002-11-01 2007-07-24 Streck, Inc. Hematology reagent and methods
JP4850711B2 (ja) * 2003-10-02 2012-01-11 ベックマン コールター， インコーポレイテッド 血液サンプルの有核赤血球の光学測定のリファレンスコントロール
US7198953B2 (en) * 2003-10-12 2007-04-03 Beckman Coulter, Inc. Method of using a reference control composition for measurement of nucleated red blood cells
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
EP1738163A4 (en) * 2004-04-07 2008-01-23 Beckman Coulter Inc REFERENCE CONTROL COMPOSITION CONTAINING NUCLEIC RED GLOBULE COMPONENT
US7109036B2 (en) * 2004-05-13 2006-09-19 Beckman Coulter, Inc. Hematology reference control containing an immature granulocyte component
US7354767B2 (en) * 2006-03-16 2008-04-08 Beckman Coulter, Inc. Reference control composition containing a nucleated red blood cell component made of non-nucleated blood cells
US7754487B2 (en) * 2006-11-14 2010-07-13 Beckman Coulter, Inc. Hematology linearity control composition, system and method of use
US7618821B2 (en) * 2007-04-13 2009-11-17 Streck, Inc. Simulated blood components and methods
CN101311724B (zh) * 2007-05-24 2014-11-12 深圳迈瑞生物医疗电子股份有限公司 单群白细胞模拟离子、包含单群白细胞模拟离子的校准物及其制备方法
CN101311725B (zh) * 2007-05-25 2014-03-26 深圳迈瑞生物医疗电子股份有限公司 一种五分类白细胞质控物及其制备方法
CN101561443B (zh) * 2008-04-15 2013-08-21 深圳迈瑞生物医疗电子股份有限公司 五分类白细胞模拟物粒子、其制备方法以及含该模拟粒子的质控物和校准物
US20100086962A1 (en) 2008-10-08 2010-04-08 Streck, Inc. Hematology controls and methods
CN101887059B (zh) * 2009-05-11 2014-03-19 深圳迈瑞生物医疗电子股份有限公司 嗜酸性粒细胞模拟物、制备方法及全血质控物
CN102109430B (zh) * 2009-12-25 2013-11-06 深圳迈瑞生物医疗电子股份有限公司 有核红细胞模拟粒子，血液质控物及其制备方法和用途
US20140051063A1 (en) * 2011-04-28 2014-02-20 Beckman Coulter, Inc. Hematology control compositions with extended stability
EP3039477B1 (en) 2013-08-26 2021-10-20 S.D. Sight Diagnostics Ltd. Digital microscopy systems, methods and computer program products
EP3859425B1 (en) 2015-09-17 2024-04-17 S.D. Sight Diagnostics Ltd. Methods and apparatus for detecting an entity in a bodily sample
CA3018536A1 (en) 2016-03-30 2017-10-05 S.D. Sight Diagnostics Ltd Distinguishing between blood sample components
EP3455626B1 (en) 2016-05-11 2025-08-06 S.D. Sight Diagnostics Ltd. Performing optical measurements on a sample
EP4177593A1 (en) 2016-05-11 2023-05-10 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
WO2018022991A1 (en) 2016-07-29 2018-02-01 Streck, Inc. Suspension composition for hematology analysis control
CN111788471B (zh) 2017-11-14 2023-12-12 思迪赛特诊断有限公司 用于光学测量的样品载体
CN111366737A (zh) * 2018-12-26 2020-07-03 深圳市帝迈生物技术有限公司 血细胞分析仪用质控物及其制备方法、血细胞分析仪
MX2022004703A (es) 2019-10-22 2022-05-11 S D Sight Diagnostics Ltd Contabilidad de errores en mediciones opticas.
CA3160702A1 (en) 2019-12-12 2021-06-17 S.D. Sight Diagnostics Ltd Artificial generation of a color blood smear image
EP4073492A1 (en) 2019-12-12 2022-10-19 S.D. Sight Diagnostics Ltd. Analyzing an analyte disposed within a medium
BR112022011233A2 (pt) 2019-12-12 2022-08-30 S D Sight Diagnostics Ltd Detecção de plaquetas em uma amostra sanguínea
WO2025245513A1 (en) 2024-05-24 2025-11-27 Beckman Coulter, Inc. Assessing and enhancing biological analyzer functionality through particle staining
WO2025245510A1 (en) 2024-05-24 2025-11-27 Beckman Coulter, Inc. Patient and control sample based analyzer evaluation
WO2025245511A1 (en) 2024-05-24 2025-11-27 Beckman Coulter, Inc. Control particles for volumetric assessment

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2656508A (en) * 1949-08-27 1953-10-20 Wallace H Coulter Means for counting particles suspended in a fluid
US3502974A (en) * 1966-05-23 1970-03-24 Coulter Electronics Signal modulated apparatus for generating and detecting resistive and reactive changes in a modulated current path for particle classification and analysis
US3741875A (en) * 1970-10-30 1973-06-26 Mount Sinai Res Foundation Inc Process and apparatus for obtaining a differential white blood cell count
BE790042A (nl) * 1971-10-14 1973-04-13 Coulter Electronics Werkwijze voor het classifiseren van deeltjes
US3873467A (en) * 1974-02-01 1975-03-25 United Medical Lab Inc Hematologic reference control
US4219440A (en) * 1979-06-06 1980-08-26 Coulter Electronics, Inc. Multiple analysis hematology reference control reagent and method of making the same
US4299726A (en) * 1979-05-07 1981-11-10 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor
US4358394A (en) * 1979-05-07 1982-11-09 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability
US4324686A (en) * 1979-06-11 1982-04-13 R & D Systems, Inc. Hematology control composition and methods for its use
US4436821A (en) * 1982-04-12 1984-03-13 Streck Laboratories, Inc. Simulated human platelets from red blood cells
US4485175A (en) * 1983-01-03 1984-11-27 Coulter Electronics, Inc. Method for three-volume differential determination of lymphocyte, monocyte and granulocyte populations of leukocytes
US4579824A (en) * 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
US4745074A (en) * 1984-02-23 1988-05-17 Cooper-Lipotech Partnership Blood-fluid composition for cell lysis system
US4704364A (en) * 1984-05-18 1987-11-03 Coulter Electronics, Inc. Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
US4751179A (en) * 1984-05-31 1988-06-14 Coulter Electronics, Inc. Method and reagents for differential determination of four populations of leukocytes in blood
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
US5008201A (en) * 1990-05-24 1991-04-16 Streck Laboratories, Inc. Simulated human platelets from red blood cells
EP0628167B1 (en) * 1992-02-24 2000-08-23 Coulter Corporation Hematology control composition for leukocyte analogs; and methods for their preparation and use

Also Published As

Publication number Publication date
DE69329274T2 (de) 2001-04-12
CA2129832A1 (en) 1993-08-25
AU665413B2 (en) 1996-01-04
AU3736693A (en) 1993-09-13
JPH07504038A (ja) 1995-04-27
EP0628167A4 (en) 1996-10-30
US5320964A (en) 1994-06-14
WO1993017330A1 (en) 1993-09-02
BR9305952A (pt) 1997-10-21
US5512485A (en) 1996-04-30
JP3391451B2 (ja) 2003-03-31
ATE195810T1 (de) 2000-09-15
NO943115L (no) 1994-09-01
EP0628167A1 (en) 1994-12-14
KR950700539A (ko) 1995-01-16
EP0628167B1 (en) 2000-08-23
DE69329274D1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
NO943115L (no) Hematologikontrollsammensetning for leukocyttanaloger; og fremgangsmåte for fremstilling og anvendelse
Rovera et al. Terminal differentiation in human promyelocytic leukaemic cells in the absence of DNA synthesis
NO943116L (no) Suspensjonsmedia for hematologisk sammensetning og fremgangsmåte for dens anvendelse
AU1285592A (en) Methods for increasing extracellular adenosine and for stabilizing mast cells
DE3580973D1 (de) Geraet zur bestrahlung von blutteilen.
ES8609719A1 (es) Una suspension fluida de control de referencia para hemato- logia
DE3572179D1 (en) Blood coagulation inhibiting proteins, process for preparing them and their use
HK10386A (en) Hematological reference control compositions
AU5817496A (en) Process for producing erythropoietin containing no animal pr oteins
DE69033033D1 (de) Verbesserte kontrollverfahren für stabile blutkoagulation
FI854328A0 (fi) Kontroll foer gasanalysatorer foer blod och hemoglobinanalys.
AU566710B2 (en) Irradiate leukocytes in blood in extracorporeal circuit
NO180544C (no) Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
DE3260830D1 (en) Process for the manufacture of globin or blood cell protein and heme from hemoglobin
BG50035A3 (bg) Метод за получаване на човешки левкоцити и гама-интерферони
Alter et al. Control of the simian fetal hemoglobin switch at the progenitor cell level
EP0061277A3 (en) Anaerobic method for preserving whole blood, tissue and components containing living mammalian cells
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
Karube A study on the mechanism of thrombosis in ovarian hyperstimulation syndrome (OHSS)
AU6208790A (en) A stabilizer for improving the recovery of coagulation factors in blood samples
HK53791A (en) Po-man's photosynthesis in men's blood to cure cancer (phmdcc)
JPS5753408A (en) Blood coagulation accelerator based on human protein
Wildevuur-van Hamersveld et al. Hematologic abnormalities in extracorporeal circuits (ECC)
JPS5618591A (en) Production of substance capable of differentiation and multiplication of stem cells of human granulocyte